The US Tissue Engineered Skin Substitute Market represents a major share of the global regenerative medicine industry, supported by advanced healthcare infrastructure, substantial healthcare expenditure, and strong investments in biotechnology research. The growing prevalence of chronic wounds, diabetic ulcers, burn injuries, and age-related skin conditions is driving the adoption of innovative...